Phase I Study of XZ120 in Malignant Tumors

Clinical trial NCT06206915 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06206915
Sponsor: Shandong New Time Pharmaceutical Co., LTD
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancies

Start date: 2024-02-01
Primary completion: 2025-02-01
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.